Edition:
United Kingdom

Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

150.00SEK
11:23am GMT
Change (% chg)

-2.00kr (-1.32%)
Prev Close
152.00kr
Open
150.00kr
Day's High
150.00kr
Day's Low
150.00kr
Volume
36
Avg. Vol
23,962
52-wk High
207.00kr
52-wk Low
103.50kr

Chart for

About

Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): kr749.96
Shares Outstanding(Mil.): 5.28
Dividend: --
Yield (%): --

Financials

  IBTb.ST Industry Sector
P/E (TTM): -- 30.49 33.71
EPS (TTM): -8.91 -- --
ROI: -42.09 14.98 14.48
ROE: -42.09 16.30 15.99

Earnings vs. Estimates